Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy

Journal Title: Iranian journal of diabetes and obesity (IJDO) - Year 2024, Vol 16, Issue 2

Abstract

Objective: The VEGF function blockage effectively reduces the progression of diabetic retinopathy. Ranibizumab and bevacizumab are some anti-VEGF monoclonal antibodies (mAb). Considering the importance of affinity maturation of ranibizumab, we aimed to find the essential amino acids of the ranibizumab antibody (Ab). Materials and Methods: We tried to find the important amino acids of this antibody via Paratome, Meta-PPISP, and the WESA web server. Subsequently, these amino acids were mutated to improve the binding affinity of the Ab variants to antigen (Ag). In this regard, the ranibizumab anti-VEGF-A was mutated. The structural docking prediction of the ranibizumab-VEGF-A complex was used for the design and validation of ranibizumab with a higher affinity for binding to VEGF-A. Finally, we measured the binding affinity of Ab variants to Ag by computational docking. Results: Bioinformatic analyzes such as molecular docking and dynamics showed that several mutant variants successfully improved the properties of Ab binding compared to the wild-type Ab. Conclusion: Consistent with the use of anti-VEGF monoclonal antibodies in the treatment of diabetic retinopathy, the mutant variants of ranibizumab may be potential candidates for stronger affinity binding to VEGF, which may affect the specificity and sensitivity of the antibody.

Authors and Affiliations

Fateme Sefid,Kimia Monshizadeh,Ghasem Azamirad,Mohammad Yahya Vahidi Mehrjardi,

Keywords

Related Articles

Environmental Factors before the Onset of Type 1 Diabetes Mellitus: A Case-Control Study

Objective: The role of environmental factors in the development of type1 diabetes mellitus (T1D) is inconclusive. This study aimed to investigate the associations between selected environmental factors and T1D. Material...

Prevalence and Impact of Thyroid Disorders on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

Objective: Diabetes and thyroid disorders (TD) are two prevalent endocrine conditions in adults. While the association between TD and type 1 diabetes is well documented, the relationship between type 2 diabetes mellitus...

Effectiveness of Acceptance and Commitment Group Therapy with the Islamic Approach to Reduce Anxiety and Depression in Type II Diabetes People in Yazd

Objective: The purpose of this study was to investigate the effectiveness of acceptance and commitment based group therapy (ACT) with the Islamic approach to reduce anxiety and depression in patients with type II diabete...

Comparison of the Effects of Total Body Resistance Exercise and Traditional Resistance Training on the Immune System Biomarker in Inactive Obese Women

Objective: This study aimed to compare the effect of eight weeks of traditional resistance training and total body resistance exercise (TRX) on the immune system of obese sedentary women. Materials and Methods: In this...

Vildagliptin-Associated Bullous Pemphigoid: A Case Report

Objective: Bullous pemphigoid is a rare autoimmune skin disorder characterized by blistering, urticarial lesions, which are sometimes associated with adverse drug reactions. Vildagliptin is an oral anti-diabetic agent th...

Download PDF file
  • EP ID EP738095
  • DOI -
  • Views 34
  • Downloads 0

How To Cite

Fateme Sefid, Kimia Monshizadeh, Ghasem Azamirad, Mohammad Yahya Vahidi Mehrjardi, (2024). Antibody Engineering to Enhancement of Ranibizumab Binding Affinity for the Prevention and Treatment of Diabetic Retinopathy. Iranian journal of diabetes and obesity (IJDO), 16(2), -. https://europub.co.uk/articles/-A-738095